Avanos Medical

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$175,000
$167,500
$179,600
$170,400
Gross Profit
92,100
89,800
99,300
92,900
EBITDA
-63,900
21,400
-406,600
24,400
EBIT
-73,900
11,800
-417,700
12,700
Net Income
-76,800
6,600
-397,300
4,300
Net Change In Cash
175,000
167,500
179,600
170,400
Free Cash Flow
-4,200
19,000
53,100
20,000
Cash
90,300
97,000
107,700
89,000
Basic Shares
46,800
46,800
46,000
46,600

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$687,800
$673,300
$684,100
$744,600
Gross Profit
381,300
379,700
394,200
379,900
EBITDA
-345,600
50,600
77,800
48,900
EBIT
-391,100
7,100
36,700
10,600
Net Income
-392,100
-61,800
50,500
6,300
Net Change In Cash
687,800
673,300
684,100
744,600
Cost of Revenue
12,200
11,000
Free Cash Flow
82,900
14,600
71,600
66,300
Cash
107,700
87,700
127,700
118,500
Basic Shares
46,000
46,600
47,300
48,600

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
$0.17
2025-03-31
$0.14
2024-12-31
$0.43